An integrated approach to atrial fibrillation in frail, multimorbid and polymedicated older people
Presenting authorGregory Y. H. LipElectrophysiology · Medical University of BiałystokGregory Y.H. Lip is Price-Evans Chair of Cardiovascular Medicine at the University of Liverpool and Honorary Consultant Cardiologist at Liverpool Heart & Chest Hospital. He is also Distinguished Professor at Aalborg University and Adjunct Professor at Seoul National University. His research focuses on the epidemiology of atrial fibrillation, pathophysiology of thromboembolism, and clinical risk scores such as CHA2DS2-VASc and HAS-BLED.
Results pending for integrated AF care in frail multimorbid elderly; leaves open whether holistic pathways improve outcomes before practice adoption.
Key result
An integrated approach to atrial fibrillation in frail, multimorbid and polymedicated older people has pending results from a late-breaking trial at ESC Congress 2026.
Expert reaction lands here the moment AFFIRMO reports.
AFFIRMO is a cluster-randomized trial across 6 European countries testing whether a mobile-health supported integrated care pathway (iABC), combining the ABC framework with comprehensive geriatric assessment, reduces all-cause unplanned hospitalizations in 1,260 older multimorbid AF patients over 12 months. Results are scheduled for presentation at ESC 2026 Hot Line 8 by Gregory Y.H. Lip. The trial has not yet reported outcomes, so expert commentary is limited to design-phase and pre-results framing.
Absolute Event Rate: 0% vs 0%
Gregory Y. H. Lip (Thu,) reported a other. An integrated approach to atrial fibrillation in frail, multimorbid and polymedicated older people has pending results from a late-breaking trial at ESC Congress 2026.